The downfall of TBA-354 – a possible explanation for its neurotoxicity via mass spectrometric imaging-Reference-Cited by-同舟云学术

The downfall of TBA-354 – a possible explanation for its neurotoxicity via mass spectrometric imaging

Published:2017-10-13 Issue:9 Volume:48 Page:938-944
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Ntshangase Sphamandla¹,Shobo Adeola¹,Kruger Hendrik G.¹,Asperger Arndt²,Niemeyer Dagmar²,Arvidsson Per I.¹³,Govender Thavendran¹,Baijnath Sooraj¹

Affiliation:

1. Catalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, South Africa,

2. Bruker Daltonik, GmbH, Bremen, Germany, and

3. Science for Life Laboratory, Drug Discovery & Development Platform & Division of Translational Medicine and Chemical Biology, Development of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2017.1375168

Reference32 articles.

1. Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction

2. Arnaud CH. (2017). Pharma embraces imaging mass spec [online]. C&EN Chemical & Engineering News. Available from: http://cen.acs.org/articles/95/i23/Pharma-embraces-imaging-mass-spec.html [last accessed 7 Jun 2017]

3. Evidence for the presence of clofazimine and its distribution in the healthy mouse brain

4. Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry

5. Reversible brain MRI changes in acyclovir neurotoxicity

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis;AAPS PharmSciTech;2023-06-08

2. Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models;Journal of Controlled Release;2023-02

3. Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent;Bioorganic & Medicinal Chemistry Letters;2022-09

4. Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study;Journal of Biomolecular Structure and Dynamics;2022-05-14

5. Π-Π Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives Leading to Promising Therapy Against Tuberculosis in Zebrafish and Mouse Models;2022-03-11